Concord Total Other Income Expense Net vs Selling And Marketing Expenses Analysis
| CCM Stock | USD 5.70 0.17 3.07% |
Concord Medical financial indicator trend analysis is way more than just evaluating Concord Medical Services prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Concord Medical Services is a good investment. Please check the relationship between Concord Medical Total Other Income Expense Net and its Selling And Marketing Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Total Other Income Expense Net vs Selling And Marketing Expenses
Total Other Income Expense Net vs Selling And Marketing Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Concord Medical Services Total Other Income Expense Net account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have no relationship.
The correlation between Concord Medical's Total Other Income Expense Net and Selling And Marketing Expenses is 0.08. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Concord Medical Services, assuming nothing else is changed. The correlation between historical values of Concord Medical's Total Other Income Expense Net and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Concord Medical Services are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Total Other Income Expense Net i.e., Concord Medical's Total Other Income Expense Net and Selling And Marketing Expenses go up and down completely randomly.
Correlation Coefficient | 0.08 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Total Other Income Expense Net
Selling And Marketing Expenses
Most indicators from Concord Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Concord Medical Services current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. As of the 21st of September 2024, Selling General Administrative is likely to drop to about 190.2 M. In addition to that, Tax Provision is likely to grow to about (23.3 M)
Concord Medical fundamental ratios Correlations
Click cells to compare fundamentals
Concord Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Concord Medical fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 4.3B | 5.3B | 6.2B | 6.0B | 6.1B | 4.0B | |
| Other Current Liab | 274.7M | 243.2M | 301.1M | 325.2M | 674.1M | 707.8M | |
| Total Current Liabilities | 627.5M | 512.1M | 804.5M | 1.1B | 2.0B | 2.0B | |
| Total Stockholder Equity | (122.8M) | (663.0M) | (1.4B) | (1.9B) | (2.1B) | (2.0B) | |
| Other Liab | 287.0M | 270.2M | 230.1M | 268.9M | 309.2M | 324.7M | |
| Cash | 74.3M | 334.3M | 157.4M | 158.3M | 58.1M | 55.2M | |
| Other Assets | 661.1M | 409.9M | 250.6M | 24.0M | 27.6M | 26.2M | |
| Long Term Debt | 1.3B | 2.0B | 2.2B | 2.5B | 2.0B | 2.1B | |
| Good Will | 210.4M | 213.7M | 581.9M | 575.4M | 661.7M | 694.8M | |
| Common Stock Shares Outstanding | 43.4M | 43.4M | 43.4M | 43.7M | 50.2M | 47.0M | |
| Other Current Assets | 4.3M | 31.4M | 6.0M | 24.3M | 412.9M | 433.6M | |
| Total Liab | 2.4B | 2.9B | 3.5B | 4.0B | 4.3B | 4.5B | |
| Intangible Assets | 532.5M | 522.8M | 1.1B | 762.1M | 721.1M | 461.5M | |
| Property Plant Equipment | 2.5B | 3.2B | 3.8B | 3.9B | 4.4B | 4.7B | |
| Short Long Term Debt Total | 1.9B | 2.4B | 2.7B | 3.2B | 3.3B | 3.5B | |
| Property Plant And Equipment Net | 2.5B | 3.2B | 3.3B | 3.4B | 3.7B | 3.9B | |
| Current Deferred Revenue | 3.2M | 87.7M | 81.0M | 100.8M | 59.4M | 32.4M | |
| Net Debt | 1.8B | 2.0B | 2.6B | 3.1B | 3.2B | 3.4B | |
| Retained Earnings | (1.8B) | (2.5B) | (3.3B) | (3.8B) | (4.1B) | (3.9B) | |
| Accounts Payable | 8.3M | 18.6M | 102.5M | 146.7M | 129.2M | 135.7M | |
| Non Current Assets Total | 4.0B | 4.7B | 5.6B | 5.2B | 5.4B | 3.3B | |
| Non Currrent Assets Other | 661.1M | 107.5M | 13.6M | 23.2M | 6.3M | 6.0M | |
| Cash And Short Term Investments | 74.3M | 334.3M | 157.4M | 158.3M | 58.1M | 55.2M | |
| Net Receivables | 199.6M | 280.4M | 383.0M | 512.8M | 73.5M | 69.8M | |
| Liabilities And Stockholders Equity | 4.3B | 5.3B | 6.2B | 6.0B | 6.1B | 4.3B | |
| Non Current Liabilities Total | 1.8B | 2.4B | 2.7B | 2.9B | 2.4B | 1.3B | |
| Other Stockholder Equity | 1.8B | 1.8B | 1.9B | 1.9B | 2.0B | 1.7B | |
| Property Plant And Equipment Gross | 2.5B | 3.4B | 3.6B | 3.8B | 4.1B | 4.3B | |
| Total Current Assets | 282.5M | 676.0M | 584.5M | 759.8M | 617.2M | 736.9M | |
| Accumulated Other Comprehensive Income | (97.3M) | (46.4M) | (29.5M) | (27.8M) | (65.4M) | (62.1M) | |
| Short Term Debt | 341.3M | 162.5M | 319.8M | 548.5M | 1.1B | 1.1B | |
| Short Term Investments | 50M | 35.2M | 25.0M | 2.7M | 2.4M | 2.3M | |
| Inventory | 4.3M | 21.6M | 38.1M | 84.8M | 40.3M | 28.3M | |
| Net Tangible Assets | (865.7M) | (1.4B) | (2.6B) | (2.8B) | (2.5B) | (2.4B) | |
| Long Term Investments | 64.9M | 313.0M | 390.6M | 437.9M | 394.7M | 319.4M | |
| Short Long Term Debt | 328.4M | 148.9M | 299.4M | 512.6M | 1.0B | 537.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Concord Stock
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.60) | Revenue Per Share 123.019 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.